Femasys Inc. Revenue
Femasys Inc. (FEMY) reported Revenue of $331.83 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-14
- Femasys Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $331.83K, a 18.92% decline year-over-year.
- Femasys Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $424.89K, a 24.50% increase year-over-year.
- Femasys Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $813.39K, a 39.86% increase year-over-year.
- Femasys Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $729.39K, a 31.44% increase year-over-year.
- Femasys Inc. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $2.29M, a 40.77% increase from fiscal 2024.
- Femasys Inc. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $1.63M, a 51.97% increase from fiscal 2023.
- Femasys Inc. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $1.07M, a 11.13% decline from fiscal 2022.
- Femasys Inc. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $1.21M, a 2.25% increase from fiscal 2021.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $331.83K 10-Q · filed 2026-08-14 | $756.72K 10-Q · filed 2026-08-14 | $1.57M derived: sum of 3 quarters · filed 2026-08-14 | $2.30M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $424.89K 10-Q · filed 2026-05-08 | $1.24M derived: sum of 2 quarters · filed 2026-05-08 | $1.97M derived: sum of 3 quarters · filed 2026-05-08 | $2.38M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $813.39K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.54M derived: sum of 2 quarters · filed 2026-03-31 | $1.95M derived: sum of 3 quarters · filed 2026-08-14 | $2.29M 10-K · filed 2026-03-31 |
| 2025-09-30 | $729.39K 10-Q · filed 2025-11-14 | $1.14M derived: sum of 2 quarters · filed 2026-08-14 | $1.48M 10-Q · filed 2025-11-14 | $2.06M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $409.27K 10-Q · filed 2026-08-14 | $750.53K 10-Q · filed 2026-08-14 | $1.33M derived: sum of 3 quarters · filed 2026-08-14 | $1.89M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $341.26K 10-Q · filed 2026-05-08 | $922.84K derived: sum of 2 quarters · filed 2026-05-08 | $1.48M derived: sum of 3 quarters · filed 2026-05-08 | $1.70M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $581.58K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.14M derived: sum of 2 quarters · filed 2026-03-31 | $1.36M derived: sum of 3 quarters · filed 2026-03-31 | $1.63M 10-K · filed 2026-03-31 |
| 2024-09-30 | $554.91K 10-Q · filed 2025-11-14 | $776.39K derived: sum of 2 quarters · filed 2025-11-14 | $1.05M 10-Q · filed 2025-11-14 | $1.26M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $221.48K 10-Q · filed 2025-08-08 | $492.62K 10-Q · filed 2025-08-08 | $705.74K derived: sum of 3 quarters · filed 2025-08-08 | $950.10K derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $271.14K 10-Q · filed 2025-05-08 | $484.25K derived: sum of 2 quarters · filed 2025-05-08 | $728.61K derived: sum of 3 quarters · filed 2025-05-08 | $1.05M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $213.11K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $457.47K derived: sum of 2 quarters · filed 2025-03-27 | $777.99K derived: sum of 3 quarters · filed 2025-03-27 | $1.07M 10-K · filed 2025-03-27 |
| 2023-09-30 | $244.36K 10-Q · filed 2024-11-12 | $564.88K derived: sum of 2 quarters · filed 2024-11-12 | $858.86K 10-Q · filed 2024-11-12 | $1.09M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $320.51K 10-Q · filed 2024-08-08 | $614.50K 10-Q · filed 2024-08-08 | $848.74K derived: sum of 3 quarters · filed 2024-08-08 | $1.20M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $293.98K 10-Q · filed 2024-05-09 | $528.23K derived: sum of 2 quarters · filed 2024-05-09 | $875.68K derived: sum of 3 quarters · filed 2024-05-09 | $1.18M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $234.24K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $581.70K derived: sum of 2 quarters · filed 2024-03-28 | $884.81K derived: sum of 3 quarters · filed 2024-03-28 | $1.21M 10-K · filed 2024-03-28 |
| 2022-09-30 | $347.46K 10-Q · filed 2023-11-14 | $650.57K derived: sum of 2 quarters · filed 2023-11-14 | $971.97K 10-Q · filed 2023-11-14 | $1.23M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $303.11K 10-Q · filed 2023-08-10 | $624.52K 10-Q · filed 2023-08-10 | $878.85K derived: sum of 3 quarters · filed 2023-08-10 | $1.15M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $321.40K 10-Q · filed 2023-05-11 | $575.73K derived: sum of 2 quarters · filed 2023-07-24 | $845.31K derived: sum of 3 quarters · filed 2023-07-24 | $1.17M derived: sum of 4 quarters · filed 2023-07-24 |
| 2021-12-31 | $254.33K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-07-24 | $523.91K derived: sum of 2 quarters · filed 2023-07-24 | $849.91K derived: sum of 3 quarters · filed 2023-07-24 | $1.18M 10-K/A · filed 2023-07-24 |
| 2021-09-30 | $269.58K 10-Q · filed 2022-11-10 | $595.59K derived: sum of 2 quarters · filed 2022-11-10 | $925.36K 10-Q · filed 2022-11-10 | $1.21M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $326.01K 10-Q · filed 2022-08-10 | $655.78K 10-Q · filed 2022-08-10 | $936.75K derived: sum of 3 quarters · filed 2022-08-10 | $1.25M derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $329.77K 10-Q · filed 2022-05-11 | $610.74K derived: sum of 2 quarters · filed 2022-05-11 | $923.95K derived: sum of 3 quarters · filed 2022-05-11 | $1.11M derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | $280.96K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $594.17K derived: sum of 2 quarters · filed 2022-03-24 | $777.41K derived: sum of 3 quarters · filed 2022-03-24 | $1.04M 10-K · filed 2022-03-24 |
| 2020-09-30 | $313.21K 10-Q · filed 2021-11-12 | $496.44K derived: sum of 2 quarters · filed 2021-11-12 | $756.95K 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $183.23K 10-Q · filed 2021-08-11 | $443.75K 10-Q · filed 2021-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |